SPRAY

Semax Spray (30mg)

In Stock

Nomenclature & Synonyms

Semax is scientifically named as Met-Glu-His-Phe-Pro-Gly-Pro. It is a synthetic heptapeptide derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH). It is commonly referred to as ACTH(4-10) in research literature. There are no specific research or development codes publicly associated with this compound.

Structural Characteristics

The peptide sequence for Semax is Met-Glu-His-Phe-Pro-Gly-Pro, consisting of 7 amino acids. Notably, Semax is modified by the addition of a C-terminal Pro-Gly-Pro sequence which is not present in native ACTH. It does not contain disulfide bridges or other typical peptide modifications like acetylation or amidation.

Molecular Pharmacology

Semax primarily targets melanocortin receptors, specifically acting as an agonist at the MC4 receptor. It is thought to influence signaling pathways such as cAMP/PKA due to its derivation from ACTH. Semax's selectivity towards MC4 is noted to be higher compared to other melanocortin receptors.

Research Applications

  • Semax was first synthesized in the 1980s by Russian researchers, specifically at the Institute of Molecular Genetics of the Russian Academy of Sciences.
  • Studies have demonstrated its potential effects on neuronal activity and cognitive processes.
  • It has been explored primarily in in vitro systems and animal models to assess its neuroprotective properties.

Technical Properties

Semax is soluble in sterile water at 1 mg/mL. For research use, it is recommended that this compound be stored in lyophilized form at -20°C for long-term stability.

Compliance

For laboratory research use only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, or preventive applications.

$110.00
Earn 11,000 points
In Stock (87 available)
Viewed 0 times today
Purchased 0 times this week
(87 available)

Product Description

Nomenclature & Synonyms

Semax is scientifically named as Met-Glu-His-Phe-Pro-Gly-Pro. It is a synthetic heptapeptide derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH). It is commonly referred to as ACTH(4-10) in research literature. There are no specific research or development codes publicly associated with this compound.

Structural Characteristics

The peptide sequence for Semax is Met-Glu-His-Phe-Pro-Gly-Pro, consisting of 7 amino acids. Notably, Semax is modified by the addition of a C-terminal Pro-Gly-Pro sequence which is not present in native ACTH. It does not contain disulfide bridges or other typical peptide modifications like acetylation or amidation.

Molecular Pharmacology

Semax primarily targets melanocortin receptors, specifically acting as an agonist at the MC4 receptor. It is thought to influence signaling pathways such as cAMP/PKA due to its derivation from ACTH. Semax's selectivity towards MC4 is noted to be higher compared to other melanocortin receptors.

Research Applications

  • Semax was first synthesized in the 1980s by Russian researchers, specifically at the Institute of Molecular Genetics of the Russian Academy of Sciences.
  • Studies have demonstrated its potential effects on neuronal activity and cognitive processes.
  • It has been explored primarily in in vitro systems and animal models to assess its neuroprotective properties.

Technical Properties

Semax is soluble in sterile water at 1 mg/mL. For research use, it is recommended that this compound be stored in lyophilized form at -20°C for long-term stability.

Compliance

For laboratory research use only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, or preventive applications.

Research Benefits

  • Ideal for research purposes
The benefits listed above are research benefits only. Products are not sold for human use or consumption.

Technical Specifications

SKU
CHP-506696-H60
CAS Number
80714-61-0
Molecular Formula
C₃₇H₅₁N₉O₁₀S
Molecular Weight
813.9 g/mol
Purity
99%
Form
liquid
Concentration
300mcg/mL
Category
Sprays, Liquid

Product reviews

Preparing verified reviews…
Selank Spray (30mg)
SPRAY

Selank Spray (30mg)

Nomenclature & Synonyms

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It is also referred to by the research code TP-7 and is related to the parent compound Tuftsin, a natural peptide factor.

Structural Characteristics

The amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro comprises seven residues. Selank is a derivative of the immunomodulatory peptide tuftsin, consisting of the natural tuftsin fragment with a tail to enhance stability and receptor interaction. It lacks modifications such as N-terminal or C-terminal acetylation or amidation.

Molecular Pharmacology

Selank primarily interacts with neuromodulatory neurotransmitter systems, including serotonin and dopamine systems. It acts as an agonist in these pathways, often impacting the expression of neurotrophic factors. The modulation of cAMP signaling pathways and MAO-A enzyme inhibition are two studied mechanisms, though no specific receptor binding is well-documented.

Research Applications

  • Synthesized in the late 1990s by the Institute of Molecular Genetics of the Russian Academy of Sciences
  • Investigated for its role in cognitive enhancement and anxiolytic properties in rodent behavioral studies
  • Studies have demonstrated neurotransmitter modulation and cognitive function improvement in vitro

Technical Properties

Selank is soluble in sterile water at 2mg/mL.

Compliance

For laboratory research use only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, or preventive applications.